Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Savely A Sheetikov"'
Autor:
Dmitry Lioznov, Irina Amosova, Savely A Sheetikov, Ksenia V Zornikova, Yana Serdyuk, Grigory A Efimov, Mikhail Tsyferov, Mikhail Khmelevskii, Andrei Afanasiev, Nadezhda Khomyakova, Dmitry Zubkov, Anton Tikhonov, Tao Zhu, Luis Barreto, Vitalina Dzutseva
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0278878 (2023)
BackgroundTo determine the immunogenicity, efficacy, reactogenicity, and safety of a single dose of recombinant adenovirus type-5 vectored COVID-19 vaccine (Ad5-nCoV, 5 × 1010 viral particles per 0.5 mL dose), we conducted a single-dose, randomised,
Externí odkaz:
https://doaj.org/article/08e8fcb72ba646b8815b34a3a91ff517
Autor:
Ksenia V. Zornikova, Alexandra Khmelevskaya, Savely A. Sheetikov, Dmitry O. Kiryukhin, Olga V. Shcherbakova, Aleksei Titov, Ivan V. Zvyagin, Grigory A. Efimov
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-11 (2022)
The clonotypes of CD8+ T cells specific to 9 SARS-CoV-2 epitopes are identified from COVID-19 convalescent patients and the longitudinal study of these clonotypes reveals that T cell persistence correlates with TCR diversity.
Externí odkaz:
https://doaj.org/article/4dc9d57d7cbd4b779de5a7b2e6740e78
Immunogenic epitope panel for accurate detection of non-cross-reactive T cell response to SARS-CoV-2
Autor:
Aleksei Titov, Regina Shaykhutdinova, Olga V. Shcherbakova, Yana V. Serdyuk, Savely A. Sheetikov, Ksenia V. Zornikova, Alexandra V. Maleeva, Alexandra Khmelevskaya, Dmitry V. Dianov, Naina T. Shakirova, Dmitry B. Malko, Maxim Shkurnikov, Stepan Nersisyan, Alexander Tonevitsky, Ekaterina Khamaganova, Anton V. Ershov, Elena Y. Osipova, Ruslan V. Nikolaev, Dmitry E. Pershin, Viktoria A. Vedmedskia, Michael Maschan, Victoria R. Ginanova, Grigory A. Efimov
Publikováno v:
JCI Insight, Vol 7, Iss 9 (2022)
The ongoing COVID-19 pandemic calls for more effective diagnostic tools. T cell response assessment serves as an independent indicator of prior COVID-19 exposure while also contributing to a more comprehensive characterization of SARS-CoV-2 immunity.
Externí odkaz:
https://doaj.org/article/f3a2a8cc553a465b87e4da680fdb63db
Autor:
Ksenia V. Zornikova, Alexandra Khmelevskaya, Savely A. Sheetikov, Dmitry O. Kiryukhin, Olga V. Shcherbakova, Aleksei Titov, Ivan V. Zvyagin, Grigory A. Efimov
T cells play a pivotal role in reducing disease severity during SARS-CoV-2 infection and formation of long-term immune memory. We studied 50 COVID-19 convalescent patients and found that T cell response was induced more frequently and persisted longe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e6aafdaccb8252ac13e87881eb340de
https://doi.org/10.1101/2022.04.18.22273961
https://doi.org/10.1101/2022.04.18.22273961
Autor:
Dmitry Lioznov, Irina Amosova, Savely A. Sheetikov, Ksenia V. Zornikova, Yana Serdyuk, Grigory A. Efimov, Mikhail Tsyferov, Mikhail Khmelevskii, Andrei Afanasiev, Nadezhda Khomyakova, Dmitry Zubkov, Anton Tikhonov, Tao Zhu, Luis Barreto, Vitalina Dzutseva
Background To determine the immunogenicity, efficacy, reactogenicity, and safety of a single dose of recombinant adenovirus type-5 vectored COVID-19 vaccine (Ad5-nCoV, 5 × 1010 viral particles per 0.5 mL dose), we conducted a single-dose, randomised
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd04a5ae89b742b9b6b674b5ee71880
https://doi.org/10.1101/2022.03.01.22271507
https://doi.org/10.1101/2022.03.01.22271507
Immunogenic epitope panel for accurate detection of non-cross-reactive T cell response to SARS-CoV-2
Autor:
Aleksei Titov, Regina Shaykhutdinova, Olga V. Shcherbakova, Yana Serdyuk, Savely A. Sheetikov, Ksenia V. Zornikova, Alexandra V. Maleeva, Alexandra Khmelevskaya, Dmitry V. Dianov, Naina T. Shakirova, Dmitry B. Malko, Maxim Shkurnikov, Stepan Nersisyan, Alexander Tonevitsky, Ekaterina Khamaganova, Anton V. Ershov, Elena Y. Osipova, Ruslan V. Nikolaev, Dmitry E. Pershin, Viktoria A. Vedmedskia, Mikhail Maschan, Victoria Ginanova, Grigory A. Efimov
Publikováno v:
JCI insight. 7(9)
The ongoing COVID-19 pandemic calls for more effective diagnostic tools, and T cell response assessment can serve as an independent indicator of prior COVID-19 exposure while also contributing to a more comprehensive characterization of SARS-CoV-2 im
Autor:
V. M. Ukrainskaya, Denis Y. Logunov, Alexandra V. Maleeva, O. Ivanova, Inna V. Dolzhikova, Grigory A. Efimov, Iuliia O. Peshkova, Leila Ovchinnikova, Elizaveta Romanova, Savely A. Sheetikov, Alexandra Gracheva, Ksenia V. Zornikova, Alexander Mitin, Ioanna N. Filimonova, Anna Tvorogova, Alexey A. Komissarov, Nelli B. Naigovzina, Anna Navoikova, Mikhail Pashenkov, Yakov A. Lomakin, Liudmila Shevkova, Aleksander Deryabin, Anna Panova, D. Vorobyeva, E. Maryukhnich, N. Pinegina, Yury P. Rubtsov, Denis Lagutkin, Musa Khaitov, Viktoria Komogorova, Yana Serdyuk, Oksana Musatova, Walaa Asaad, Irina Vasilyeva, Anastasia Samoilova, Vladimir Murugin, Afraa Mohammad, Pavel Volchkov, Anatoliy Vinokurov, Daria Potashnikova, Natalia Kompantseva, Ivan Molodtsov, Anastasia Kizilova, Evgenii Kegeles, Nawar Sakr, Anna Trufanova, Alexander Shpektor, Elena Vasilieva, Aleena Saidova, Olga Mityaeva, Nina Murugina, Naina T. Shakirova, Nina Sharova, Anastasia Komova, Ilya Kofiadi, Anastasia Shemetova, Anna Budikhina, Margarita Nikonova, Alsalloum Almaqdad
Background Coronavirus disease COVID-19 has spread worldwide extremely rapidly. Although many individuals have been infected and have cleared the virus, developing virus-specific antibodies and effector/memory T cells, an important question still to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ad609d16d6841d8058374892924746a
https://doi.org/10.1101/2021.08.19.21262278
https://doi.org/10.1101/2021.08.19.21262278
Autor:
Anna Kuchmiy, Savely A. Sheetikov, Dmitrii Romaniuk, Grigory A. Efimov, Artem Pilunov, S Y Filkin, F N Rosov
Publikováno v:
Молекулярная биология. 53:456-466
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for hematopoietic malignancies. The graft-derived donor lymphocytes are capable of eliminating the residual recipient malignant cells in the course of allogen
Autor:
Savely A. Sheetikov, Ksenia V. Zornikova, Anton Shmelev, Maria Malasheva, Alina S. Shomuradova, Aleksei Titov, Bella Biderman, Dmitry Vladimirovich Dianov, Artem Pilunov, Yana Serdyuk, Dmitry V. Bagaev, Naina T. Shakirova, Alexandra Khmelevskaya, Dmitry Kiryukhin, Alexandra V. Maleeva, Murad Vagida, Dmitry B. Malko, Ekaterina G. Khamaganova, Alexander V. Ivanov, Anastasia Pivnyuk, Mikhail Shugay, Dmitrii S. Shcherbinin, Iuliia O. Peshkova
Publikováno v:
SSRN Electronic Journal.
Understanding the hallmarks of the adaptive immune response to SARS-CoV-2 is critical for fighting the COVID-19 pandemic. We assessed the antibody and T-cell reactivity in COVID-19 convalescent patients and healthy donors sampled both prior to and du
Autor:
Yulia Davydova, P R Yefimova, Alexander Vdovin, Savely A. Sheetikov, S Y Filkin, Valery G. Savchenko, Nikolay M. Kapranov, Evgeny S. Egorov, Ekaterina G. Khamaganova, Elena N. Parovichnikova, Larisa A. Kuzmina, Grigory A. Efimov, Mikhail Drokov
Publikováno v:
Biochemistry (Moscow). 81:1371-1383
Patients undergoing allogeneic hematopoietic stem cell transplantation have a high risk of cytomegalovirus reactivation, which in the absence of T-cell immunity can result in the development of an acute inflammatory reaction and damage of internal or